{"id":1016116,"date":"2026-11-02T11:57:24","date_gmt":"2026-11-02T16:57:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/"},"modified":"2026-11-02T11:57:24","modified_gmt":"2026-11-02T16:57:24","slug":"sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/","title":{"rendered":"Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WALTHAM, Mass., Nov.  02, 2026  (GLOBE NEWSWIRE) &#8212; Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to develop novel medicines for cystic fibrosis (CF), today announced that management will participate in fireside chats at the following upcoming investor events:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:6pt\">Guggenheim&#8217;s 3rd Annual Healthcare Innovation Conference fireside chat on Monday, November 9<sup>th<\/sup>, 2026, at 10:30 a.m. ET; and<\/li>\n<li style=\"margin-bottom:6pt\">Stifel\u2019s 2026 Healthcare Conference fireside chat on Tuesday, November 10<sup>th<\/sup>, 2026, at 8:40 a.m. ET\n<\/li>\n<\/ul>\n<p>Live webcasts can be accessed in the \u2018Investors\u2019 section of Sionna\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6POZQtkEziD6WcNGS88XLK1UXj7tJm9AKzWSPbqDbIhapJnO6GVMey3F_ehAfBqZ2o-vY3dQKEloIINE3RfTHgPt1CsBuU32TCt6OSz3v2Vfq7_jMEVwuSFWeFp0B7AY\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.sionnatx.com<\/a>. Replays will also be available following the events.<\/p>\n<p>\n        <strong>About\u00a0Sionna Therapeutics<\/strong>\u00a0<br \/>Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that improve the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Sionna\u2019s goal is to deliver differentiated medicines for people living with CF that can restore their CFTR function to as close to normal as possible by directly stabilizing CFTR\u2019s nucleotide binding domain 1 (NBD1), which Sionna believes is central to potentially unlocking meaningful improvements in clinical outcomes and quality of life for people with CF. For more information about Sionna, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PZpBRhPWA7zN6bSkdVgM_fFUM9odASinO9DFozg6XmP4F4uYAuKbqQXUkpmZRuZJJ6Dzz1tbL-AXu7yIuQ89Fd1EsjktPESlz-CarEYXhIU=\" rel=\"nofollow\" target=\"_blank\">www.sionnatx.com<\/a>.<\/p>\n<p>Sionna intends to use its Investor Relations website as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor Sionna\u2019s Investor Relations website, in addition to following Sionna\u2019s press releases, SEC filings, public conference calls, presentations, and webcasts.<\/p>\n<p>\n        <strong>Investor &amp; Media Contact<\/strong>\u00a0<br \/>Juliet Labadorf\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=o28KFSe3SpJzQSxn137ZTOCin9LS3TfRlBabXdcIvEMb481eKtAIojvwcQl4CSnUXkThXHS50EDt0MhMIMcMeT0YQc7ElfA-e9oXVjfGeDQ=\" rel=\"nofollow\" target=\"_blank\">ir@sionnatx.com<\/a>\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u02pk2uXH3GQJv68EekABYkzyZYPY21wl6C0_By6ihnS1-w5jb44U14pW3D8-mZ4u-e_8gT9rXN891GNk7o3zaA-v3znheq8HDrOG2XS1Yg=\" rel=\"nofollow\" target=\"_blank\">media@sionnatx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTc1NiM3OTIyNjA0IzIyOTUwMjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/M2M5Zjc1OWEtMDMwZi00OGY3LTgwYjktMzQ2NjdiNTMxNTVkLTEzMDY1NzAtMjAyNi0xMS0wMi1lbg==\/tiny\/Sionna-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to develop novel medicines for cystic fibrosis (CF), today announced that management will participate in fireside chats at the following upcoming investor events: Guggenheim&#8217;s 3rd Annual Healthcare Innovation Conference fireside chat on Monday, November 9th, 2026, at 10:30 a.m. ET; and Stifel\u2019s 2026 Healthcare Conference fireside chat on Tuesday, November 10th, 2026, at 8:40 a.m. ET Live webcasts can be accessed in the \u2018Investors\u2019 section of Sionna\u2019s website at https:\/\/investors.sionnatx.com. Replays will also be available following the events. About\u00a0Sionna Therapeutics\u00a0Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1016116","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to develop novel medicines for cystic fibrosis (CF), today announced that management will participate in fireside chats at the following upcoming investor events: Guggenheim&#8217;s 3rd Annual Healthcare Innovation Conference fireside chat on Monday, November 9th, 2026, at 10:30 a.m. ET; and Stifel\u2019s 2026 Healthcare Conference fireside chat on Tuesday, November 10th, 2026, at 8:40 a.m. ET Live webcasts can be accessed in the \u2018Investors\u2019 section of Sionna\u2019s website at https:\/\/investors.sionnatx.com. Replays will also be available following the events. About\u00a0Sionna Therapeutics\u00a0Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by &hellip; Continue reading &quot;Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-02T16:57:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTc1NiM3OTIyNjA0IzIyOTUwMjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences\",\"datePublished\":\"2026-11-02T16:57:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\\\/\"},\"wordCount\":276,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTc1NiM3OTIyNjA0IzIyOTUwMjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\\\/\",\"name\":\"Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTc1NiM3OTIyNjA0IzIyOTUwMjA=\",\"datePublished\":\"2026-11-02T16:57:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTc1NiM3OTIyNjA0IzIyOTUwMjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTc1NiM3OTIyNjA0IzIyOTUwMjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences - Market Newsdesk","og_description":"WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to develop novel medicines for cystic fibrosis (CF), today announced that management will participate in fireside chats at the following upcoming investor events: Guggenheim&#8217;s 3rd Annual Healthcare Innovation Conference fireside chat on Monday, November 9th, 2026, at 10:30 a.m. ET; and Stifel\u2019s 2026 Healthcare Conference fireside chat on Tuesday, November 10th, 2026, at 8:40 a.m. ET Live webcasts can be accessed in the \u2018Investors\u2019 section of Sionna\u2019s website at https:\/\/investors.sionnatx.com. Replays will also be available following the events. About\u00a0Sionna Therapeutics\u00a0Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by &hellip; Continue reading \"Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-02T16:57:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTc1NiM3OTIyNjA0IzIyOTUwMjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences","datePublished":"2026-11-02T16:57:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/"},"wordCount":276,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTc1NiM3OTIyNjA0IzIyOTUwMjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/","name":"Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTc1NiM3OTIyNjA0IzIyOTUwMjA=","datePublished":"2026-11-02T16:57:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTc1NiM3OTIyNjA0IzIyOTUwMjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTc1NiM3OTIyNjA0IzIyOTUwMjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sionna-therapeutics-to-participate-in-upcoming-november-2026-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1016116"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016116\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1016116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1016116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1016116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}